Search Results - "Cirovic, Olivera"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    617 A Phase I study of a tumor-targeted, fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors

    617 A Phase I study of a tumor-targeted, fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors by Melero, Ignacio, Baradji, Maria Lostes, Spanggaard, Iben, Lee, Dae, Spicer, James, Thistlethwaite, Fiona C, Symeonides, Stefan, Oh, Do-Youn, Hollebecque, Antoine, Rusterholz, Corinne, Cirovic, Olivera, Zhao, Yvonne, Kratochwil, Nicole, Reis, Bernhard, Epp, Alexandra, Kazantzidis, Georgios, Moreno, Victor

    Published in Journal for immunotherapy of cancer (01-11-2023)
    “…BackgroundFAP-CD40 is a second-generation, bispecific, FAP-targeted CD40 agonist antibody, which was developed to overcome systemic toxicities and the narrow…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    The nuclear RNA binding protein RBP33 influences mRNA and spliced leader RNA abundance in Trypanosoma brucei

    The nuclear RNA binding protein RBP33 influences mRNA and spliced leader RNA abundance in Trypanosoma brucei by Cirovic, Olivera, Trikin, Roman, Hoffmann, Anneliese, Doiron, Nicholas, Jakob, Martin, Ochsenreiter, Torsten

    Published in Molecular and biochemical parasitology (01-03-2017)
    “…RNA recognition motif (RRM) containing proteins are important regulators of gene expression in trypanosomes. Here we expand our current knowledge on the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Whole proteome analysis of the protozoan parasite Trypanosoma brucei using stable isotope labeling by amino acids in cell culture and mass spectrometry

    Whole proteome analysis of the protozoan parasite Trypanosoma brucei using stable isotope labeling by amino acids in cell culture and mass spectrometry by Cirovic, Olivera, Ochsenreiter, Torsten

    “…The single-celled protozoan Trypanosoma brucei spp. is the causative agent of human African trypanosomiasis and nagana in cattle. Quantitative proteomics for…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  4. 4
    291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors

    291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors by Barlesi, Fabrice, Lolkema, Martijn, Kristoffer Staal Rohrberg, Hierro, Cinta, Marabelle, Aurelien, Albiruni Abdul Razak, Teixeira, Luis, Boni, Valentina, Miller, Wilson H, Aggarwal, Charu, Stern, Martin, Cirovic, Olivera, Romagnoli, Barbara, Christen, Randolph, Dodia, Raksha, Smart, Kevin, Reis, Bernhard, Staedler, Nicolas, Watson, Carl, Steeghs, Neeltje

    Published in Journal for immunotherapy of cancer (01-11-2020)
    “…BackgroundSelicrelumab is a human IgG2 agonistic anti-CD40 monoclonal antibody. Binding of the antibody to CD40 expressed on antigen-presenting cells results…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: